Biostem Technologies Inc
OTC:BSEM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biostem Technologies Inc
OTC:BSEM
|
US |
|
I
|
Immuneering Corp
NASDAQ:IMRX
|
US |
|
Resources & Energy Group Ltd
ASX:REZ
|
AU |
|
Nice Ltd
NASDAQ:NICE
|
IL |
|
C
|
Chin Huay PCL
SET:CH
|
TH |
|
Deutsche Telekom AG
MIL:DTE
|
DE |
|
Accord Financial Corp
TSX:ACD
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BSEM's stock price target?
Not Available
BSEM doesn't have any price targets made by Wall Street professionals.
What is Biostem Technologies Inc's Revenue forecast?
Projected CAGR
483%
For the last 14 years the
compound annual growth rate for
Biostem Technologies Inc's revenue is
29%.
The projected
CAGR
for the next 1 year is
483%.